Medicina Laboratorial Dr. Carlos Da Silva Torres
Medicina Laboratorial Dr. Carlos Da Silva Torres is recorded as a service provider in 7 clinical trials. Explore its recorded services, study phases and therapeutic areas, with trial-level operational learnings where available.
Clinical trial experience
Showing 7 of 7 trials · Latest update first
Bioequivalence of Apixaban 5 mg Film-Coated Tablets: A Single-Dose, Open-Label, Randomized, Two-Sequence, Two-Treatment, Two-Period Crossover Study in Healthy Subjects Under Fasting Conditions.
Sponsor Laboratorios Cinfa S.A.
- Start (EU)
- Latest update
- Estimated end
- Not reported
Comparative Bioavailability of Ruxolitinib 20 mg Film-Coated Tablets: A Single-Dose, Open-Label, Randomized, Two-Treatment, Two-Sequence, Two-Period Crossover Study in Healthy Participants Under Fasting Conditions.
Sponsor Bluepharma Industria Farmaceutica S.A.
- Start (EU)
- Latest update
- Estimated end
- Not reported
Bioequivalence of Tofacitinib 10 mg Film-Coated Tablets: A Single-Dose, Open-Label, Randomized, Two-Sequence, Two-Treatment, Two-Period Crossover Study in Healthy Subjects Under Fasting Conditions.
Sponsor Bluepharma Industria Farmaceutica S.A.
- Start (EU)
- Latest update
- Estimated end
- Not reported
Pharmacokinetics of Nicorandil 40 mg Extended-Release Capsules: A Single-Dose, Open-Label, Randomized, Two-Sequence, Two-Treatment, Two-Period Crossover Study in Healthy Subjects Under Fasting and Fed Conditions.
Sponsor Auxilius Pharma Sp. z o.o.
- Start (EU)
- Latest update
- Estimated end
- Not reported
A Single-Dose, Randomized, Open-Label, Crossover, Exploratory Bioavailability Study in Healthy Volunteers of Two Formulations of Gliclazide MR Tablets 120 mg (I.R.I.S.) and Two Diamicron® MR Tablets 60 mg (I.R.I.S.) under Fasting and Fed Conditions and Oral Solution of 60 mg Gliclazide (I.R.I.S.) under Fasting Conditions.
Sponsor Institut De Recherches Internationales Servier IRIS
- Start (EU)
- Latest update
- Estimated end
- Not reported
Comparative Bioavailability of Empagliflozin 25 mg Film-Coated Tablets: A Single-Dose, Open-Label, Randomized, Two-Sequence, Two-Treatment, Two-Period Crossover Study in Healthy Subjects Under Fasting Conditions.
Sponsor Tecnimede-Sociedade Tecnico-Medicinal S.A.
- Start (EU)
- Latest update
- Estimated end
- Not reported
A Phase 1 Study to Investigate the Effect of Food on the Bioavailability of a Single Cytisinicline 3 mg Tablet and Evaluation of the Pharmacokinetics of Multiple 3 mg Doses (Three Times Daily) in Healthy Adult Smokers
Sponsor Achieve Life Sciences Inc.
- Start (EU)
- Latest update
- Estimated end
- Not reported
Questions about this trial experience
What services are recorded for Medicina Laboratorial Dr. Carlos Da Silva Torres?
The 2026-10-09 snapshot links Medicina Laboratorial Dr. Carlos Da Silva Torres to 7 distinct CTIS trials. Recorded services include Laboratory services. These are study-specific roles, not a complete or independently verified capability catalogue.
Which therapeutic areas and study phases are recorded for Medicina Laboratorial Dr. Carlos Da Silva Torres?
Therapeutic-area tags are not recorded in this snapshot. Study-phase tags are not recorded. Use the filters to inspect the supporting studies; missing tags are not evidence of absent experience.
In which countries are trials linked to Medicina Laboratorial Dr. Carlos Da Silva Torres conducted?
The linked trials record locations in 1 country, including Portugal. These are trial locations, not confirmed office locations or countries where Medicina Laboratorial Dr. Carlos Da Silva Torres delivered services.
What can this page tell me about Medicina Laboratorial Dr. Carlos Da Silva Torres's trial experience?
Browse 7 distinct trials with recorded roles, sponsor names, available study dates and links to CTIS source records. No trial-level operational findings are recorded in this snapshot. Trial counts and findings do not measure the provider’s performance or establish responsibility for study outcomes.
About this data & company names
One current approved profile per CTIS trial. Services reflect recorded roles, not a complete capability catalogue or a performance ranking. Missing tags mean the information was not recorded. Country tags describe trial locations, not the provider’s service territory.
Start is the reported EU start date; latest update is the CTIS publication date; estimated end is the reported global estimate, which may be in the past. Missing dates are shown as “Not reported”. Operational learnings describe the trial as a whole and do not establish the provider’s responsibility.
Clear service synonyms are grouped; otherwise the source label is retained. Service tags show the recorded roles for each trial. This page groups 1 recorded name variant under Medicina Laboratorial Dr. Carlos Da Silva Torres. Legacy brands remain separate unless explicitly matched in the name registry.
View recorded company names
- Medicina Laboratorial Dr. Carlos Da Silva Torres S.A.